SCI Ventures

$27Mdisclosed portfolio round capital

1 Nov, 2025last investment

2portfolio companies

17team members

Analyst signals

Portfolio activity and matriculation

Metrics use all recorded activity through 21 Jul 2026 across pre seed, series b. Later-round outcomes are capped at the period end.

0%companies with a later round · 0/2

Not availablemedian round-size step-up · n=0

Not availablemedian valuation step-up · n=0

0%recorded-solo rate · 0 solo / 2 syndicated

Finance · 1 companies

These are activity signals, not fund-return metrics. Round capital is the full disclosed financing amount, not this fund's check size. “Recorded solo” means only one investor is present in the source data and is a lead signal, not verified lead status; syndicated rounds are a co-investor or follower signal. IRR, TVPI, DPI, ownership, exits, and market beta cannot be calculated from the available records.

People

Team

Adrien Cohen

Founding Managing Director, Board & Investment Committee Member

Armin Curt, MD, PhD

Professor for Paraplegiology, University of Zurich, Chief and Director Spinal Cord Injury Center

Chet Moritz, PhD

Professor of Electrical & Computer Engineering, University of Washington, Co-Director, Center for Neurotechnology

Deborah Backus, PhD

Vice President Research & Innovation, Shepherd Center, Director of Virginia C. Crawford Research Institute

Edelle Field-Fote, PT, PhD, FAPTA, FASIA

Director, Spinal Cord Injury Research, Shepherd Center; Professor, Emory University School of Medicine; Professor of the Practice, Georgia Institute of Technology

Eric Persson

Vice Chair Promobilia Foundation, Ex CEO of Novax & leading positions at Axel Johnson/Nordstjernan

Fotis Hasiotis

Ex Managing Director Jefferies, Lazard, Merrill Lynch, Ex Global Co-Head of Financial Sponsors

Ian Curtis

Board Member, ISRT and Reeve Foundation; Chairman, HPC plc, Former PwC Partner

Jean Baptiste Wautier

Chair of Investment Committee, Ex Chief Investment Officer BC Partners

Kiran Dallenbach, PhD

Partner at Biomed VC, Life Science VC, PhD ETH Zürich

Murray Blackmore, PhD

Professor Marquette University, Leader in nerve regeneration & genetic control

Peter Luckeneder

Global CFO Wings for Life

Phil Horner, PhD

Professor of Neuroregeneration, Director, Center for Neuroregeneration at Houston Methodist

Rob Brownstone, MD, PhD

Professor of Neurosurgery, Brain Research UK, Head of the Division of Neurosurgery UCL

Roman Rothaermel, PhD

Investment Principal, Biotech Operator, PhD Neuroscience University of Oxford

Tom Londres

Board Member, Reeve Foundation; CEO, Metro Commercial, Inc.

Willie Watt

Chair of the Scottish National Investment Bank, Ex Managing Director 3i

Portfolio

Investments

Full financing histories for portfolio companies. Highlighted rounds are those where SCI Ventures is recorded as an investor.

OrangeX

crypto

Finance

OrangeX is a centralized cryptocurrency exchange that provides spot, perpetual futures and copy-trading services with deep liquidity, low fees and 24/7 support.

Series B1 Aug, 2025$20M roundSyndicated · 2 disclosed investors

Tatakai

crypto

Stealth

Angel1 Nov, 2025$7M roundSyndicated · 9 disclosed investors